References
- Johnson KR, Lehn DA, Reeves R. Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol Cell Biol 1989; 9(5):2114-23; PMID:2701943; http://dx.doi.org/10.1128/MCB.9.5.2114
- Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai BM, Fidanza V, Giancotti V, Santoro M, et al. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 1996; 13(11):2439-46; PMID:8957086
- Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995; 376(6543):771-4; PMID:7651535; http://dx.doi.org/10.1038/376771a0
- Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer 2007; 7(12):899-910. Review; PMID:18004397; http://dx.doi.org/10.1038/nrc2271
- Fedele M, Fidanza V, Battista S, Pentimalli F, Klein-Szanto AJ, Visone R, De Martino I, Curcio A, Morisco C, Del Vecchio L, et al. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res 2006; 66(5):2536-43; PMID:16510570; http://dx.doi.org/10.1158/0008-5472.CAN-05-1889
- Foti D, Chiefari E, Fedele M, Iuliano R, Brunetti L, Paonessa F, Manfioletti G, Barbetti F, Brunetti A, Croce CM, et al.Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 2005; 11(7):765-73; PMID:15924147; http://dx.doi.org/10.1038/nm1254
- Pierantoni GM, Conte A, Rinaldo C, Tornincasa M, Gerlini R, Federico A, Valente D, Medico E, Fusco A. Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes. Oncotarget 2015; 6(19):17342-53; PMID:26009897.
- Federico A, Forzati F, Esposito F, Arra C, Palma G, Barbieri A, Palmieri D, Fedele M, Pierantoni GM, De Martino I, Fusco A. Hmga1/Hmga2 double knock-out mice display a “superpygmy” phenotype. Biol Open 2014; 3(5):372-8; PMID:24728959; http://dx.doi.org/10.1242/bio.20146759
- Sotillo R, Hernando E, Díaz-Rodríguez E, Teruya-Feldstein J, Cordón-Cardo C, Lowe SW, Benezra R. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007; 11(1):9-23; PMID:17189715; http://dx.doi.org/10.1016/j.ccr.2006.10.019
- Wang Q, Liu T, Fang Y, Xie S, Huang X, Mahmood R, Ramaswamy G, Sakamoto KM, Darzynkiewicz Z, Xu M, Dai W. BUBR1 deficiency results in abnormal megakaryopoiesis. Blood 2004; 103(4):1278-85; PMID:14576056; http://dx.doi.org/10.1182/blood-2003-06-2158
- Schliekelman M, Cowley DO, O'Quinn R, Oliver TG, Lu L, Salmon ED, Van Dyke T. Impaired Bub1 function in vivo compromises tension-dependent checkpoint function leading to aneuploidy and tumorigenesis.. Cancer Res 2009; 69(1):45-54; PMID:19117986; http://dx.doi.org/10.1158/0008-5472.CAN-07-6330
- Ricke RM, van Deursen JM. Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation. Cell Cycle 2011; 10(21):3645-51; PMID:22033440; http://dx.doi.org/10.4161/cc.10.21.18156
- Lin SF, Lin PM, Yang MC, Liu TC, Chang JG, Sue YC, Chen TP. Expression of hBUB1 in acute myeloid leukemia. Leuk Lymphoma 2002; 43:385-91; PMID:11999574; http://dx.doi.org/10.1080/10428190290006206
- Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403:503-11; PMID:10676951; http://dx.doi.org/10.1038/35000501
- van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415:530-6; PMID:11823860; http://dx.doi.org/10.1038/415530a
- Grabsch H, Takeno S, Parsons WJ, Pomjanski N, Boecking A, Gabbert HE, Mueller W. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer-association with tumour cell proliferation. J. Pathol 2003; 200:16-22; PMID:12692836; http://dx.doi.org/10.1002/path.1324
- Shigeishi H, Oue N, Kuniyasu H, Wakikawa A, Yokozaki H, Ishikawa T, Yasui W. Expression of Bub1 gene correlates with tumor proliferating activity in human gastric carcinomas. Pathobiology 2001; 69:24-29; PMID:11641614; http://dx.doi.org/10.1159/000048754
- Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005; 5:773-85; PMID:16195750; http://dx.doi.org/10.1038/nrc1714
- Gordon DJ, Resio B, Pellman D. Causes and consequences of aneuploidy in cancer. Nat Rev Genet 2012; 13:189-203; PMID:22269907
- Bargiela-Iparraguirre J, Prado-Marchal L, Pajuelo-Lozano N, Jiménez B, Perona R, Sánchez-Pérez I. Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells. Cell Cycle 2014; 13(22):3590-601; PMID:25483095; http://dx.doi.org/10.4161/15384101.2014.962952
- Hu M, Liu Q, Song P, Zhan X, Luo M, Liu C, Yang D, Cai Y, Zhang F, Jiang F, et al. Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells. Oncol Rep 2013; 29(1):185-92; PMID:23128493
- McGrogan BT, Gilmartin B, Carney DN, McCann A.Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta 2008; 1785(2):96-132
- Chanel-Vos C, Giannakakou P. CENP-E checks in microtubule-drug resistance. Cell Cycle 2010; 9(8):1456; PMID:20421712; http://dx.doi.org/10.4161/cc.9.8.11382
- Esposito F, Tornincasa M, Chieffi P, De Martino I, Pierantoni GM, Fusco A. High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene. Cancer Res 2010; 70(13):5379-88; PMID:20530667; http://dx.doi.org/10.1158/0008-5472.CAN-09-4199
- Pierantoni GM, Battista S, Pentimalli F, Fedele M, Visone R, Federico A, Santoro M, Viglietto G, Fusco A. A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas. Carcinogenesis 2003; 24(12):1861-9; PMID:12970064; http://dx.doi.org/10.1093/carcin/bgg149
- Livak KJ, Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25(4):402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262
- Valente D, Bossi G, Moncada A, Tornincasa M, Indelicato S, Piscuoglio S, Karamitopoulou ED, Bartolazzi A, Pierantoni GM, Fusco A, et al. HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity. Oncotarget 2015; 6(12):10320-34; PMID:25868975; http://dx.doi.org/10.18632/oncotarget.3583